Singapore is attacking the scale-up valley of death with a S$1 billion enhancement to Startup SG Equity. Announced in Budget 2026, the top-up expands the scheme beyond early-stage funding to cover growth-stage companies, particularly those in deep tech that need larger and longer-term capital to commercialise . The move sits alongside the Enterprise Financing Scheme, creating a layered capital stack for SMEs at different stages of maturity.
Why Growth-Stage Capital Is Different
Early-stage financing funds product development and market validation. Growth-stage financing funds manufacturing scale-up, regulatory approvals, overseas market entry, and working capital for larger order volumes. The quantum and tenor are different, and so is the risk profile. Private growth capital has tightened globally, making it harder for deep-tech firms to raise the larger cheques needed to move from pilot to production .
Startup SG Equity’s expansion responds to that gap by allowing the government to co-invest alongside private investors in growth-stage rounds. The scheme does not replace private capital; it catalyses it. When the government takes a co-investment position, private investors gain confidence that the company has passed a public due-diligence threshold, which can crowd in additional funding.
The EFS Connection: Debt and Equity Working Together
For SMEs that are past the startup phase but not yet ready for a public listing, EFS Venture Debt remains a complementary tool. Venture debt uses warrants or redeemable convertible preference shares to bridge the risk gap between traditional bank debt and pure equity . A growth-stage deep-tech SME might use Startup SG Equity for a Series B round and EFS Venture Debt for equipment or bridge financing, avoiding excessive dilution while still funding the capital expenditure needed to scale.
The two schemes serve different balance-sheet purposes. Equity strengthens the capital base and supports long-horizon R&D; venture debt provides non-dilutive financing for assets and working capital. Used together, they reduce the “valley” between early-stage grants and mainstream bank credit.
A Real-World Lens: The Advanced Manufacturing Scale-Up
Imagine a Singapore-based advanced materials startup with a proven product, a pilot plant, and initial customer contracts. It needs S$15 million to build a commercial-scale facility and another S$3 million for working capital as orders ramp up. A pure equity round would be heavily dilutive for founders. A bank loan would be difficult without a track record of profitable operations. Startup SG Equity can anchor the growth round, while EFS Venture Debt can finance the equipment and provide a liquidity buffer. The combination keeps the cap table cleaner and aligns debt service with the facility’s cash generation.
Eligibility and the Broader Ecosystem Signal
Startup SG Equity is aimed at innovative, high-growth companies, and the expansion to growth stage broadens the pool of eligible firms. The EFS Venture Debt facility remains available to innovative enterprises with growth potential, subject to participating financial institutions’ assessment. Core EFS eligibility — Singapore registration, 30% local shareholding, and a S$500 million group turnover ceiling — continues to apply .
The Budget 2026 announcement also included a second S$1.5 billion tranche of the Anchor Fund to attract high-quality listings, reinforcing the message that Singapore wants companies to scale and list at home . For SMEs, the practical takeaway is that the financing architecture is becoming more stage-aware. Growth capital is no longer a policy afterthought; it is an explicit pillar of the enterprise financing ecosystem.
